Diagnostic Accuracy of SurePathâ„¢ in EUS-FNA (NCT05394129) | Clinical Trial Compass
TerminatedNot Applicable
Diagnostic Accuracy of SurePathâ„¢ in EUS-FNA
Stopped: Difficulty in recruiting research subjects
South Korea89 participantsStarted 2019-04-09
Plain-language summary
It is a prospective randomized controlled study to evaluate the diagnostic accuracy of SurePathâ„¢ liquid-based cytology in endoscopic ultrasound-guided sampling.
Who can participate
Age range19 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients who signed the agreement after the explanation
* Patients suspected of esophageal, gastric, duodenal subepithelial tumors, periesophageal and perigastric lymph nodes from radiological(CT, MR, ultrasound) or endoscopic examinations.
Exclusion Criteria:
* Those who did not agree with the study
* Patients younger than 19 years of age
* Serious mental patients
* Patients with severe accompanying diseases (ESRD, advanced COPD, severe heart failure, sever mental illness)
* Pregnant women
* If EUS is difficult due to previous surgery (Billroth II or TG with R-en-Y)
* Patient with blood clotting abnormality
* If there is a risk of tract seeding after examination